Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: Correlations with symptom change

Journal of Neurology Neurosurgery and Psychiatry

Volumn 72, Issue 1, 2002, Pages 106-110

  Ngan, E T C ^a   Lane, C J ^a   Ruth, T J ^b   Liddle, P F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TRIUMP Positron Emission Tomography program ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MECHANISM; FEMALE; FRONTAL CORTEX; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY;

ADULT; ENERGY METABOLISM; FEMALE; FRONTAL LOBE; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SINGLE-BLIND METHOD; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036145131     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.72.1.106     Document Type: Article

References (30)

1. Patterns of cerebral blood flow in schizophrenia
2. Single photon emission tomography with 99mTc-exametazime in unmedicated schizophrenic patients
3. Clinical symptoms and regional cerebral blood flow in schizophrenia
4. Regional brain function in hallucinations: A study of regional cerebral blood flow with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations, and normal controls
5. A functional neuroanatomy of hallucinations in schizophrenia
6. Increased blood flow in Broca's area during auditory hallucinations in schizophrenia
7. Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naive patients
8. Clozapine effects on glucose metabolic rate in striatum and frontal cortex
9. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol
10. Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: A pilot study
11. The brain metabolic patterns of clozapine and fluphenazine treated patients with schizophrenia during a continuous performance task
12. Positron emission tomography studies of the basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients
13. PET studies of drug interaction with brain regional glucose metabolism
14. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia
15. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia
16. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and non-responsive schizophrenic patients
17. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia
18. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
19. Antipsychotic drug-induced dysphoria
20. Receptor occupancy by antipsychotics: Concepts and findings
21. Symptoms of schizophrenia: Methods, meaning, and mechanism
22. A rating scale for extrapyramidal side effects
23. Quantitative comparison of three and two dimensional PET with human brain studies
24. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2. fluoro-deoxy-D-glucose: Validation of method
25. Detecting activations in PET and fMRI: Levels of inference and power
26. The symptoms of chronic schizophrenia: A re-examination of the positive-negative dichotomy
27. Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of "hypofrontality" with recovery from acute schizophrenio
28. New insights into prefrontal function in schizophrenia
29. Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus